The breast cancer genes PRIORS probabilities program9, gives MES estimations of disruption of natural splice sites and also computes the creation of new donor and acceptor splice sites using NNSplice, yet only for BRCA1 and BRCA2 genes (Vallée et al., 2016). This evidence concerns the gene BRCA1 and breast carcinoma.